Bajaj, J. S. Alcohol, liver disease and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 16, 235–246 (2019).
Seo, W. & Jeong, W. I. Hepatic non-parenchymal cells: master regulators of alcoholic liver disease? World J. Gastroenterol. 22, 1348–1356 (2016).
Suh, Y. G. & Jeong, W. I. Hepatic stellate cells and innate immunity in alcoholic liver disease. World J. Gastroenterol. 17, 2543–2551 (2011).
Szabo, G. Gut-liver axis in alcoholic liver disease. Gastroenterology 148, 30–36 (2015).
Gao, B., Ahmad, M. F., Nagy, L. E. & Tsukamoto, H. Inflammatory pathways in alcoholic steatohepatitis. J. Hepatol. 70, 249–259 (2019).
Mueller, S. et al. Carcinogenic etheno DNA adducts in alcoholic liver disease: correlation with cytochrome P-4502E1 and fibrosis. Alcohol Clin. Exp. Res. 42, 252–259 (2018).
Lu, Y. & Cederbaum, A. I. CYP2E1 and oxidative liver injury by alcohol. Free Radic. Biol. Med. 44, 723–738 (2008).
Ge, X. et al. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J. Biol. Chem. 289, 22672–22691 (2014).
Cai, Y. et al. Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity. JCI Insight 2, e92634 (2017).
Iracheta-Vellve, A. et al. Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice. J. Hepatol. 63, 1147–1155 (2015).
Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821–832 (2010).
Petrasek, J. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest 122, 3476–3489 (2012).
Hirsova, P. et al. Extracellular vesicles in liver pathobiology: small particles with big impact. Hepatology 64, 2219–2233 (2016).
Eguchi, A. et al. Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood. Hepatology 65, 475–490 (2017).
Saha, B., Momen-Heravi, F., Kodys, K. & Szabo, G. MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J. Biol. Chem. 291, 149–159 (2016).
Dhir, A. et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560, 238–242 (2018).
Lee, J. H. et al. Mitochondrial double-stranded RNA in exosome promotes interleukin-17 production through toll-like receptor 3 in alcoholic liver injury. Hepatology (2019) [Ahead of print].
Seo, W. et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by gammadelta T cells in liver fibrosis. Hepatology 64, 616–631 (2016).
Byun, J. S., Suh, Y. G., Yi, H. S., Lee, Y. S. & Jeong, W. I. Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J. Hepatol. 58, 342–349 (2013).
Watanabe, A. et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46, 1509–1518 (2007).
Seo, W. et al. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles. J. Hepatol. 71, 1000–1011 (2019).
Saha, B. et al. Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90. Hepatology 67, 1986–2000 (2018).
Verma, V. K. et al. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J. Hepatol. 64, 651–660 (2016).
Jeong, W. I. et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab. 7, 227–235 (2008).
Choi, W. M. et al. Glutamate signaling in hepatic stellate cells drives alcoholic steatosis. Cell Metab. 30, 877–889 e877 (2019).
Tsukamoto, H. & Lu, S. C. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 15, 1335–1349 (2001).
Lee, Y. S. & Jeong, W. I. Retinoic acids and hepatic stellate cells in liver disease. J. Gastroenterol. Hepatol. 27, 75–79 (2012).
Yi, H. S. et al. Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice. Hepatology 60, 1044–1053 (2014).
Jeong, W. I., Park, O., Radaeva, S. & Gao, B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44, 1441–1451 (2006).
Jeong, W. I., Park, O. & Gao, B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134, 248–258 (2008).
Jeong, W. I. et al. Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 53, 1342–1351 (2011).
Lee, Y. S. et al. Blockade of retinol metabolism protects T cell-induced hepatitis by increasing migration of regulatory T cells. Mol. Cells 38, 998–1006 (2015).
Bala, S., Marcos, M., Gattu, A., Catalano, D. & Szabo, G. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS ONE 9, e96864 (2014).
Michelena, J. et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology 62, 762–772 (2015).
Gustot, T. et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43, 989–1000 (2006).
Yuan, J. et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab. 30, 1172 (2019).
Parker, R., Kim, S. J. & Gao, B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nat. Rev. Gastroenterol. Hepatol. 15, 50–59 (2018).
Kusminski, C. M., Bickel, P. E. & Scherer, P. E. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat. Rev. Drug Discov. 15, 639–660 (2016).
Fedorenko, A., Lishko, P. V. & Kirichok, Y. Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 151, 400–413 (2012).
Zhong, W. et al. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am. J. Pathol. 180, 998–1007 (2012).
Lindtner, C. et al. Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci. Transl. Med. 5, 170ra114 (2013).
Tang, H. et al. Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes. Alcohol Clin. Exp. Res. 36, 214–222 (2012).
Obradovic, T. & Meadows, G. G. Chronic ethanol consumption increases plasma leptin levels and alters leptin receptors in the hypothalamus and the perigonadal fat of C57BL/6 mice. Alcohol Clin. Exp. Res. 26, 255–262 (2002).
Kalafateli, M. et al. Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis. World J. Gastroenterol. 21, 3020–3029 (2015).
Voican, C. S. et al. Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease. Liver Int. 35, 967–978 (2015).
Sebastian, B. M. et al. Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice. J. Biol. Chem. 286, 35989–35997 (2011).
Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest 112, 1796–1808 (2003).
Qin, Y. et al. Adipose inflammation and macrophage infiltration after binge ethanol and burn injury. Alcohol Clin. Exp. Res. 38, 204–213 (2014).
Naveau, S. et al. Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. J. Hepatol. 52, 895–902 (2010).
Russo, L. & Lumeng, C. N. Properties and functions of adipose tissue macrophages in obesity. Immunology 155, 407–417 (2018).
Feldstein, A. E. et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40, 185–194 (2004).
Mandal, P., Pritchard, M. T. & Nagy, L. E. Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway. World J. Gastroenterol. 16, 1330–1336 (2010).
Ikejima, K. et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 34, 288–297 (2001).
Shen, J., Sakaida, I., Uchida, K., Terai, S. & Okita, K. Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells. Life Sci. 77, 1502–1515 (2005).
Nagy, L. E. The role of innate immunity in alcoholic liver disease. Alcohol Res. 37, 237–250 (2015).
McCullough, R. L. et al. Anaphylatoxin receptors C3aR and C5aR1 are important factors that influence the impact of ethanol on the adipose secretome. Front. Immunol. 9, 2133 (2018).
Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667–685 (2014).
Habtezion, A., Nguyen, L. P., Hadeiba, H. & Butcher, E. C. Leukocyte trafficking to the small intestine and colon. Gastroenterology 150, 340–354 (2016).
Okumura, R. & Takeda, K. Maintenance of gut homeostasis by the mucosal immune system. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 92, 423–435 (2016).
Thursby, E. & Juge, N. Introduction to the human gut microbiota. Biochem J. 474, 1823–1836 (2017).
Mutlu, E. A. et al. Colonic microbiome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G966–G978 (2012).
Levitt, M. D. et al. Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism. Am. J. Physiol. 273, G951–G957 (1997).
Elamin, E. E., Masclee, A. A., Dekker, J. & Jonkers, D. M. Ethanol metabolism and its effects on the intestinal epithelial barrier. Nutr. Rev. 71, 483–499 (2013).
Forsyth, C. B., Voigt, R. M. & Keshavarzian, A. Intestinal CYP2E1: a mediator of alcohol-induced gut leakiness. Redox Biol. 3, 40–46 (2014).
Cho, Y. E. et al. Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol-inducible cytochrome P450-2E1-mediated oxidative and nitrative stress. Hepatology (2019) [Ahead of print].
Forsyth, C. B. et al. Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G185–G195 (2013).
Tripathi, A. et al. The gut-liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397–411 (2018).
Parlesak, A., Schafer, C., Schutz, T., Bode, J. C. & Bode, C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J. Hepatol. 32, 742–747 (2000).
Gu, L. et al. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J. Infect. Dis. 203, 1602–1612 (2011).
Guo, S., Al-Sadi, R., Said, H. M. & Ma, T. Y. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 182, 375–387 (2013).
Yan, A. W. et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53, 96–105 (2011).
Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562–572 (2011).
Duan, Y. et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575, 505–511 (2019).
Yuan, J. et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab. 30, 675–688 e677 (2019).
Yang, A. M. et al. Intestinal fungi contribute to development of alcoholic liver disease. J. Clin. Invest 127, 2829–2841 (2017).
Leclercq, S., De Saeger, C., Delzenne, N., de Timary, P. & Starkel, P. Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence. Biol. Psychiatry 76, 725–733 (2014).
Fleming, S. et al. Pro- and anti-inflammatory gene expression in the murine small intestine and liver after chronic exposure to alcohol. Alcohol Clin. Exp. Res. 25, 579–589 (2001).
Choudhry, M. A. et al. Impaired intestinal immunity and barrier function: a cause for enhanced bacterial translocation in alcohol intoxication and burn injury. Alcohol 33, 199–208 (2004).
Akhtar, S., Li, X., Chaudry, I. H. & Choudhry, M. A. Neutrophil chemokines and their role in IL-18-mediated increase in neutrophil O2- production and intestinal edema following alcohol intoxication and burn injury. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G340–G347 (2009).
Sibley, D. A., Fuseler, J., Slukvin, I. & Jerrells, T. R. Ethanol-induced depletion of lymphocytes from the mesenteric lymph nodes of C57B1/6 mice is associated with RNA but not DNA degradation. Alcohol Clin. Exp. Res. 19, 324–331 (1995).
Choudhry, M. A., Fazal, N., Goto, M., Gamelli, R. L. & Sayeed, M. M. Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G937–G947 (2002).
Li, X., Chaudry, I. H. & Choudhry, M. A. ERK and not p38 pathway is required for IL-12 restoration of T cell IL-2 and IFN-gamma in a rodent model of alcohol intoxication and burn injury. J. Immunol. 183, 3955–3962 (2009).
Jarvelainen, H. A. et al. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33, 1148–1153 (2001).
Guo, J. & Friedman, S. L. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenes. Tissue Repair 3, 21 (2010).
Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med 13, 1324–1332 (2007).
Zhao, E. et al. Bone marrow and the control of immunity. Cell Mol. Immunol. 9, 11–19 (2012).
Shi, C. & Pamer, E. G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762–774 (2011).
Soehnlein, O., Steffens, S., Hidalgo, A. & Weber, C. Neutrophils as protagonists and targets in chronic inflammation. Nat. Rev. Immunol. 17, 248–261 (2017).
Terai, S. et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24, 2292–2298 (2006).
Suh, Y. G. et al. CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology 56, 1902–1912 (2012).
Spahr, L. et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 48, 221–229 (2008).
Cho, Y. et al. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial. Trials 19, 696 (2018).
Shasthry, S. M., Sharma, M. K., Shasthry, V., Pande, A. & Sarin, S. K. Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial. Hepatology 70, 802–811 (2019).
Singh, V. et al. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am. J. Gastroenterol. 109, 1417–1423 (2014).
Yannaki, E. et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp. Hematol. 33, 108–119 (2005).
Lee, Y. S. et al. CX3CR1 differentiates F4/80(low) monocytes into pro-inflammatory F4/80(high) macrophages in the liver. Sci. Rep. 8, 15076 (2018).
Bonnardel, J. et al. Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche. Immunity 51, 638–654 e639 (2019).
Sakai, M. et al. Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain kupffer cell identity. Immunity 51, 655–670 e658 (2019).